Contact
searchSearch
HMP Global

Skin of Color

Featured

News
Tralokinumab Demonstrates Sustained Real-World Effectiveness in Patients With Skin of Color and Atopic Dermatitis
04/01/2026
Riya Gandhi, MA
TRACE study data show consistent improvements in disease severity and quality of life over 12 months in an underrepresented population.
TRACE study data show consistent improvements in disease severity and quality of life over 12 months in an underrepresented population.
TRACE study data show consistent...
04/01/2026
The Dermatologist
News
Immune Checkpoint Inhibitor–Associated Vitiligo Shows Earlier Onset in Melanoma and Greater Severity With Combination Therapy
03/31/2026
Riya Gandhi, MA
Single-center cohort highlights differences in timing and extent of vitiligo based on cancer type and treatment regimen.
Single-center cohort highlights differences in timing and extent of vitiligo based on cancer type and treatment regimen.
Single-center cohort highlights...
03/31/2026
The Dermatologist
News
Vitiligo Associated With Increased Cardiometabolic Risk in Large Retrospective Cohort Analysis
03/30/2026
Riya Gandhi, MA
Propensity-matched data show higher rates of diabetes, hypertension, and metabolic syndrome in adults with vitiligo.
Propensity-matched data show higher rates of diabetes, hypertension, and metabolic syndrome in adults with vitiligo.
Propensity-matched data show...
03/30/2026
The Dermatologist
Asempa
Clinical Insights
Advancing Inclusive Outcome Measures in Dermatology
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr...
03/02/2026
The Dermatologist
Nada Elbuluk
Podcasts
Inflammatory Skin Conditions in Skin of Color
01/22/2025
Nada Elbuluk, MD, MSc
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the...
01/22/2025
The Dermatologist
SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
Janiene Luke, MD
Videos
Insights on Skin of Color: Pigmentary Disorders
01/28/2022
Janiene Luke, MD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society...
01/28/2022
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist

Expert Insights

Nada Elbuluk
Podcasts
Inflammatory Skin Conditions in Skin of Color
01/22/2025
Nada Elbuluk, MD, MSc
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the...
01/22/2025
The Dermatologist
Janiene Luke, MD
Videos
Insights on Skin of Color: Pigmentary Disorders
01/28/2022
Janiene Luke, MD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society...
01/28/2022
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
DR
Videos
Notable Results From the Trials of Ruxolitinib Cream for Vitiligo
01/14/2022
David Rosmarin, MD
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights...
01/14/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Recognizing the Impact of Diseases in Skin of Color
07/16/2021
Lauren Mateja
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker...
07/16/2021
The Dermatologist
Q&As
Dr Seemal R. Desai on The Skin Bleaching Epidemic
04/25/2021
During the What’s New in Skin of Color session at AAD VMX 2021, Seemal R. Desai, MD, FAAD discussed the skin bleaching epidemic, a growing issue seen in patients of color.
During the What’s New in Skin of Color session at AAD VMX 2021, Seemal R. Desai, MD, FAAD discussed the skin bleaching epidemic, a growing issue seen in patients of color.
During the What’s New in Skin of...
04/25/2021
The Dermatologist
Feature Story
Tackling Racism in Dermatology: From Literature to Practice
11/16/2020
Lauren Mateja
The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know...
The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know...
The...
11/16/2020
The Dermatologist
Cover Story
Seeing the Spectrum: Including and Embracing Skin of Color Education in Everyday Dermatologic Practice
08/13/2020
Taylor Jamerson
Recent anti-racism movements have accentuated the longstanding need for increased training on darker skin types. The Skin of Color Society and its members are making strides in helping all dermatologists improve their knowledge.
Recent anti-racism movements have accentuated the longstanding need for increased training on darker skin types. The Skin of Color Society and its members are making strides in helping all dermatologists improve their knowledge.
Recent anti-racism movements...
08/13/2020
The Dermatologist
Feature Story
Developing a Care Program for Neglected Patient Groups: Oculocutaneous Albinism
06/11/2020
Ellen Anshelevich, BA; Victoria Williams, MD
Oculocutaneous albinism (OCA) is a rare genetic disorder that all physicians learn about in medical school, but it may never again cross your mind as a practicing dermatologist in the United States. However, in...
Oculocutaneous albinism (OCA) is a rare genetic disorder that all physicians learn about in medical school, but it may never again cross your mind as a practicing dermatologist in the United States. However, in...
...
06/11/2020
The Dermatologist
Asempa
Videos
Myth Buster: Shared Decision-Making is Easy in Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Hair Regrowth is the Only Outcome That Matters
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Children are More Resilient to Alopecia Areata Than Adults
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Patients Will Adjust to Alopecia Areata Over Time
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata...
08/06/2026
The Dermatologist
Asempa
Videos
Myth Buster: Dermatologists are Already Addressing the Psychosocial Burden of Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: If Treatment is Working, Patients can Stop it Immediately
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata...
08/06/2026
The Dermatologist
Emma Guttman
Videos
Myth Buster: Once a Patient Loses all Their Hair, Treatment Won’t Work
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: Alopecia Areata is Just Hair Loss
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than...
08/06/2026
The Dermatologist
Craiglow
Videos
Myth Buster: Alopecia Areata is No Longer an Unmet Need in Dermatology
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic...
08/06/2026
The Dermatologist
Craiglow
Videos
Myth Buster: Alopecia Areata Awareness has Solved the Stigma Problem
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Growing awareness of alopecia areata has improved visibility, but stigma remains. Dr Brittany Craiglow discusses persistent misconceptions, social challenges, and opportunities for better patient support.
Growing awareness of alopecia areata has improved visibility, but stigma remains. Dr Brittany Craiglow discusses persistent misconceptions, social challenges, and opportunities for better patient support.
Growing awareness of alopecia...
08/06/2026
The Dermatologist

News

SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
News
Ethnic Differences in Photoaging to Guide Future Developments
04/25/2021
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection...
04/25/2021
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
July/August 2026

Current Issue

August 2026
Volume 34
Issue 5
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
News
Ethnic Differences in Photoaging to Guide Future Developments
04/25/2021
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection...
04/25/2021
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use